Purdue Pharma / OxyContin Opioid Bankruptcy & Victims Settlement
Case Overview
Purdue Pharma L.P., the Connecticut-based maker of OxyContin, filed for Chapter 11 bankruptcy protection in September 2019 as it faced roughly 2,600 lawsuits from state and local governments, hospitals, Native American tribes, and individual victims alleging the company had deceptively marketed OxyContin as less addictive and more effective than competing opioids. Internal documents revealed that Purdue executives were aware of the drug's devastating abuse potential as early as the late 1990s but continued aggressive marketing tactics, including paying doctors kickbacks disguised as consulting fees and downplaying addiction risks to prescribers. The Sackler family, which owned Purdue privately, withdrew more than $10 billion from the company in the years before its bankruptcy filing.
A settlement framework negotiated in bankruptcy court required Purdue to be dissolved and reorganized into a new public benefit company with all profits directed to opioid abatement, while the Sackler family agreed to pay up to $6 billion over time — reduced from an earlier $4.5 billion proposal following U.S. Supreme Court intervention in 2023. The Supreme Court's landmark June 2024 ruling in Harrington v. Purdue Pharma (5-4) struck down the portion of the bankruptcy plan that provided the Sackler family with broad legal immunity from civil opioid lawsuits without their filing for personal bankruptcy, sending the parties back to renegotiate. The case remains one of the most closely watched mass tort bankruptcies in U.S. history.
Who May Qualify
Individuals who suffered personal injury due to addiction to or overdose from OxyContin or other Purdue opioid products, as well as surviving family members of those who died from opioid-related causes linked to Purdue drugs, may be eligible. State and local governments and healthcare entities also have separate claim tracks.
Frequently Asked Questions
Can I still file a claim against Purdue Pharma for OxyContin addiction?
The bankruptcy claims process has had several deadlines and the case is ongoing following the U.S. Supreme Court's 2024 ruling. Individuals who previously filed claims remain in the pool, but the ultimate distribution structure is still being renegotiated. Consult a mass tort attorney to understand your current eligibility.
Did the Sackler family go to jail over OxyContin?
No Sackler family member has been sentenced to prison in connection with the opioid crisis. In 2022, Purdue Pharma as a company pleaded guilty to federal criminal charges and agreed to a $225 million criminal resolution, but the Sackler family members themselves reached civil — not criminal — resolutions with most state attorneys general.
What did the Supreme Court rule in the Purdue Pharma bankruptcy case?
In June 2024, the U.S. Supreme Court ruled 5-4 in Harrington v. Purdue Pharma that the bankruptcy plan's provision granting the Sackler family sweeping legal immunity from civil opioid lawsuits was unlawful, because the Sacklers themselves had not filed for personal bankruptcy. The ruling sent the settlement back to the lower courts for renegotiation.